Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Piper Sandler Maintains Overweight on Ameris, Raises Price Target to $50

Author: Benzinga Newsdesk | July 31, 2023 11:42am
Piper Sandler analyst Casey Orr Whitman maintains Ameris (NASDAQ:ABCB) with a Overweight and raises the price target from $42 to $50.

Posted In: ABCB

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist